Improved Efficacy and Reduced Toxicity of Doxorubicin Encapsulated in Sulfatide-Containing Nanoliposome in a Glioma Model
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference69 articles.
1. New frontiers in nanotechnology for cancer treatment;F Alexis;Urol Oncol,2008
2. Emerging nanopharmaceuticals;WE Bawarski;Nanomedicine,2008
3. Nanocarriers as an emerging platform for cancer therapy;D Peer;Nat Nanotechnol,2007
4. Ligand-targeted liposomes for cancer treatment;P Sapra;Curr Drug Deliv,2005
5. A review of stimuli-responsive nanocarriers for drug and gene delivery;S Ganta;J Control Release,2008
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders;Seminars in Cancer Biology;2022-11
2. The role of size in PEGylated liposomal doxorubicin biodistribution and anti‐tumour activity;IET Nanobiotechnology;2022-08-18
3. A comprehensive review on different approaches for tumor targeting using nanocarriers and recent developments with special focus on multifunctional approaches;Journal of Pharmaceutical Investigation;2022-07-28
4. Local Delivery and Glioblastoma: Why Not Combining Sustained Release and Targeting?;Frontiers in Medical Technology;2021-11-22
5. Smart nanocarrier-based chitosan @silica coated carbon nanotubes composite for breast cancer treatment approach;International Journal of Polymeric Materials and Polymeric Biomaterials;2021-05-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3